Previous close | 97.44 |
Open | 97.76 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's range | 96.86 - 97.91 |
52-week range | 92.19 - 108.78 |
Volume | |
Avg. volume | 1,648,904 |
Market cap | 198.388B |
Beta (5Y monthly) | 0.47 |
PE ratio (TTM) | 22.07 |
EPS (TTM) | 4.40 |
Earnings date | N/A |
Forward dividend & yield | 3.78 (3.89%) |
Ex-dividend date | 07 Mar 2024 |
1y target est | 114.51 |
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.
Novartis paved the way for radiopharmaceuticals. Now, Big Pharma thinks it can do better — and biotech stocks have soared on a spate of deals.